Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > Magic Mushrooms
View:
Post by SPCEO1 on Apr 26, 2021 10:22am

Magic Mushrooms

To again highlight the insanity that TH has failed to tap into, MindMed, a Canadian company hoping to develop drugs for legit purposes using LSD and similiar illegal drugs, is spiking higher because it is about to list on NASDAQ. It has a market cap now of US$1.5 billion compared to TH's US$325.  

MindMed has one drug in phase 2A and some others in earlier stages of development. 

It is hard to take when TH has so much more but cannot seem to get the interest that companies like MindMed get depsite having products generating revenue, a NASH phase III and a very, ery intriguing cancer with a highly unusual pre-clinical Fast Track designation and the backing of a leading investor specializing in cancer stocks. In this market, those aspects of TH should be creating a much, much higher valuation than what we currently have. 

It needs to be fixed ASAP. It is unacceptable to see only TH being left behind.
Comment by stephanedodier on Apr 26, 2021 10:42am
HAVN Life Sciences Inc (HAVN.V) have a market cap of $68M CND, not all of them have stratospheric value.
Comment by SPCEO1 on Apr 26, 2021 11:08am
So many small caps I look at do not have the potential that TH has yet sell at much higher valuations. TH needs to figure out how to tap into that rather than finding the few, like the Vancouver traded HAVN, to justify TH's inability to be part of the bull market despite the impressive successes it has had in NASH and cancer. 
Comment by SPCEO1 on Apr 26, 2021 11:26am
Jsut did a quick tour of the MindMed website - they even have a section where you can purchase MindMed themed clothes, coffee mugs, etc. I am not sure TH needs that section on their new website, whenever that shows up, but it gives you an indication of how a company works to build a retail brand for its stock.
Comment by qwerty22 on Apr 26, 2021 11:43am
Feels like your beating yourself up doing these sorts of comparisons. I don't believe THTX could ever have the exuberance that mushroom stocks have. There appeal is in large parts irrational, I don't think you can have a market strat that encourages that around THTX.
Comment by Bucknelly21 on Apr 26, 2021 11:58am
how ever you spin it the bottom line is Thtx is a missive failure on the retail value side and to be quite honest on the institutional side as well, they had to give away a big chunk just to get someone to be interested. Probably going to be my last year waiting for them to figure it out. Has not only cost my time and money with them but all the other missed opportunities in this massive bull ...more  
Comment by SABBOBCAT on Apr 26, 2021 12:11pm
Buck, I believe that sentiment lagely shared. This is why I think that, baring some sort of change in strategy, the next year could be a slow one for us before an enventual buyout at 2bn. Sure great upside fot the short term holders, but a rough pill to swalloe for LT holders. It would leave a lot on the table for value in ternms of NASH and oncology.   
Comment by Bucknelly21 on Apr 26, 2021 12:13pm
On st we have about 13 new followers in the last 45 day bringing our grand total to 909. Which is unbelievably low despite all the good news we have had. While companies with nothing trading at .00004 cents a share have 80k. This just confirms what we all have been saying. They are either stupid (which I don't believe) or stubborn and don't want to admit that they are wrong in their ...more  
Comment by qwerty22 on Apr 26, 2021 12:41pm
I really don't get how searching for examples of lunacy and then moaning that THTX aren't sharing in that lunacy helps at all. Sutro looks like a solid ADC company. They are a whole Phase head of THTX with solid data in their lead program. They have three techs they are showcasing. They have two large pharma partnerships, one which just paid a $15 mil milestone for just getting ...more  
Comment by palinc2000 on Apr 26, 2021 1:09pm
What makes you think Dubuc is good with numbers?The Offering was under his responsibility and every aspect was a failure. 1- Pricing of the Units 2- Issuance of Warrants  3- Exercise Price of Warrants 4-Expiry date of Warrants 5-Share Placement in wrong Hands 6-Lack of preparedness  etcccc  I
Comment by Bucknelly21 on Apr 26, 2021 1:16pm
I said "may" lol 
Comment by palinc2000 on Apr 30, 2021 12:02pm
I am reposting this  because I feel  that this weak link in managemenent needs be to fixed ASAP 
Comment by SPCEO1 on Apr 30, 2021 12:14pm
I would live to know the backstory on the offering. I can't imagine Dubuc thought this was a sensible deal so I wonder if it was more a panicking board that led to the decision to move forward with the OO. I have heard twice now that there was some other offer on the table at some point, likely with a US based broker, but it fell through on some technicality. For all we know, Dubuc may have ...more  
Comment by realitycheck4u on Apr 30, 2021 12:34pm
This post has been removed in accordance with Community Policy
Comment by SPCEO1 on Apr 30, 2021 12:45pm
I trust Jesus will see fit to overlook you using his name like that - you should know that many believe using the Lord's name in that manner is not going to bring you any blessings. Just looking out for your earthly and eternal welfare friend. But, even if I had spoken to Paul, do you really think he was going to share with me all of the nasty aspects of how this deal went down. At best, I ...more  
Comment by palinc2000 on Apr 30, 2021 12:41pm
If true that a US deal fell thru due a technicality then its even worst,,,,,,His job was to make it work,,,,The Board approved a deal that it was presented but the head negotiator had to be the CFO,,,
Comment by SPCEO1 on Apr 30, 2021 12:52pm
Well, you are tight that he would have been the one charged with negotiationg any deal. And even if he did not like the deal he negotiated and urged the board to turn it down, he did negotiate it in the first place. So, at a minimum, he is not a very good negotiater as this was one of the worst deals I have ever seen and it came in a market where I think I could bring my have IPO'ed my big toe ...more  
Comment by jeffm34 on Apr 26, 2021 1:23pm
I think you have nailed the main problem.  It's a closed minded business culture of "only we know best".  They would rather fail miserably with their own ideas than admit they might benefit from outside advice or help.  No one is held responsible for any mistakes. 
Comment by Bucknelly21 on Apr 26, 2021 1:40pm
I just don't see how it will change until we start voting people out...
Comment by Sqidmandon on Apr 26, 2021 3:14pm
Not hard to take when you own it! I call it the Shroom Vroom! Now Therf....that's hard to take!
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities